Findings

What do systematic reviews say?

89 questions · 91 findings · 37 reviews · Musculoskeletal

Sort:Best matchNewest Highest certainty Download CSV

No studies found 42 · 46.2%GRADE not reported 6 · 6.6%Very low 3 · 3.3%Low 25 · 27.5%Moderate 12 · 13.2%High 3 · 3.3%

Febuxostat 120 mg/day vs placebo

Patient global assessment · patients with chronic cout

The review found no eligible studies for this question.

1 finding from 1 review

Febuxostat for treating chronic gout 2012 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Febuxostat 40 mg/day vs allopurinol

Patient global assessment · people with chronic gout

The review found no eligible studies for this question.

1 finding from 1 review

Febuxostat for treating chronic gout 2012 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Febuxostat 80 mg/day vs allopurinol

Patient global assessment · people with chronic gout

The review found no eligible studies for this question.

1 finding from 1 review

Febuxostat for treating chronic gout 2012 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Febuxostat 120 mg/day vs allopurinol

Patient global assessment · people with chronic gout

The review found no eligible studies for this question.

1 finding from 1 review

Febuxostat for treating chronic gout 2012 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Febuxostat 40 mg/day vs placebo

Patient global assessment · people with chronic gout

The review found no eligible studies for this question.

1 finding from 1 review

Febuxostat for treating chronic gout 2012 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

MAOIs vs placebo

Global assessment (by patient) VAS from: 0 to 10 · patients with fibromyalgia

1 finding from 1 review

Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome 2012 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 121 participants
Low

Tricyclic antidepressants vs control

Functional Status Health Assessment Questionnaire (HAQ) scale 0 to 3 · patients with pain management in rheumatoid arthritis

1 finding from 1 review

Antidepressants for pain management in rheumatoid arthritis 2011 · Cochrane Headline outcomes only
no estimate extracted
1 study · 28 participants
Low

Intervention not reported

Physician Global Assessment 100 mm visual analogue scale. Scale from: 0 to 100. ( · patients with treating osteoarthritis

1 finding from 1 review

Glucosamine therapy for treating osteoarthritis 2005 · Cochrane Headline outcomes only
no estimate extracted
1 study · 630 participants
Moderate

Intervention not reported

Patient Global Assessment (patients rated whether they were better at the end of trial than at the start of the trial) ( · patients with treating osteoarthritis

The intervention showed no clear difference in patient Global Assessment (patients rated whether they were better… (moderate certainty).

1 finding from 1 review

Glucosamine therapy for treating osteoarthritis 2005 · Cochrane Headline outcomes only
RR 1.21 [0.8, 1.82]
1 study · 118 participants
Moderate